All relevant data are within the paper. Data that support the findings of this study have been deposited in GenBank with Gene Accession Numbers (KX646706-KX646707 and KX904833-KX904838).

Introduction {#sec001}
============

The feline immunodeficiency virus (FIV) is a retrovirus of the *Lentivirus* genus that was initially isolated from colony of domestic cats in California in 1986 and has now been recognized as a common feline pathogen worldwide \[[@pone.0169739.ref001]--[@pone.0169739.ref004]\]. Infected cats may be asymptomatic for many years during which there is progressive disruption of immune function which might lead to a terminal phase with various clinical infections that is referred to as the feline acquired immunodeficiency syndrome \[[@pone.0169739.ref005]\]. Transmission of FIV is principally by parenteral inoculation of the virus in blood and saliva, presumably during fighting. Male cats are more commonly infected than females and overall prevalence rates in cats vary geographically, mostly from around 2% to 30% \[[@pone.0169739.ref005]\].

FIV occurs as seven subtypes or clades (A, B, C, D, E, F and U-NZenv) based on nucleotide sequence diversity of the envelope (*env*) gene \[[@pone.0169739.ref006]--[@pone.0169739.ref009]\]. The distribution of the clades varies with subtypes A and B being most common, and occurring very widely \[[@pone.0169739.ref008], [@pone.0169739.ref010]\]. Subtype A is common in Australia, New Zealand, the western part of the United States, South Africa and northwestern Europe \[[@pone.0169739.ref008]\]. Subtype C has been identified in Europe, Africa, Southeast Asia, New Zealand and Canada while subtypes D and E are found only infrequently, originally in Japan, Canada and Argentina \[[@pone.0169739.ref011]--[@pone.0169739.ref014]\]. Subtype F has only been described from Portugal and the US and the U-NZenv subtype only from New Zealand \[[@pone.0169739.ref007], [@pone.0169739.ref009], [@pone.0169739.ref015]\]. There is only limited data on the genotypes of the latter two subtypes.

To date, there have been five FIV-related reports in Taiwan \[[@pone.0169739.ref016]--[@pone.0169739.ref020]\], but only little data on FIV in mainland China. A study on wild Pallas' cats from China and other Asian countries identified a unique monophyletic lineage of the FIV most closely related to FIV of African wild cats \[[@pone.0169739.ref021]--[@pone.0169739.ref022]\].

In the only work on domestic cats, a serosurvey using a commercial test kit (SNAP^®^ Feline Triple^®^ Test, IDEXX Laboratories, Westbrook, ME, USA) found 9% (33/362) of cats studied in Lanzhou, northwestern China, were positive \[[@pone.0169739.ref023]\]. To provide further information on FIV infections we carried out a molecular survey on cats from five areas in mainland China.

Materials and Methods {#sec002}
=====================

The study was reviewed and approved by the Institutional Animal Care and Use Committee of the Yangzhou University College of Veterinary Medicine. Between April 2013 and June 2015, whole blood samples were collected from 615 cats in five cities (Beijing, Guangzhou, Nanjing, Shanghai and Yangzhou) in four provinces of mainland China. The cats from Yangzhou were apparently healthy animals in a shelter while those from the other cities were cats presenting to veterinary clinics for routine health examinations and vaccinations and neutering or with a variety of conditions including fever, stomatitis, and renal failure. All blood samples were collected into EDTA-containing tubes and stored at -80°C until DNA extraction.

DNA was extracted from whole blood samples with the QIAamp^®^ DNA Blood Mini Kit (QIAgen, Valencia, USA) following the protocol of the manufacturer. A negative control, diethylpyrocarbonate (DEPC)-treated ddH~2~O, was used for extraction after every 24 blood samples to confirm the absence of carry-over contamination during DNA extraction.

The FIV FRET-PCR was performed in a LightCycler 480-II real-time PCR platform as described previously \[[@pone.0169739.ref024]\]. This PCR method can detect single copies of a 176-bp *gag* gene fragment of the FIV provirus genome and can be used to differentiate subtypes A to E \[[@pone.0169739.ref024]\]. Positive controls consisted of nucleotide fragments of the *gag* regions of FIV subtypes A, B1, B2/E, C and D that were prepared as described previously \[[@pone.0169739.ref024]\]. Products obtained in the FIV FRET-PCR were further verified by electrophoresis through 2% agarose gels (BIOWEST^®^, Hong Kong, China), purified with the QIAquick PCR Purification Kit (Qiagen, Germany), and sequenced with forward and reverse primers (BGI Shanghai, China).

The *env* sequences of eight FIV subtypes (sybtype A: M25381, L00607, X69496, D37813, X69694, M36968; subtype A/B: KP330229; subtype B: D37814, U11820; subtype C: AF474246, AY600517; subtype D: D37811, D37815; subtype E: D84496, D84498; subtype F: DQ072566; subtype U: EF153977, GQ357640) ([Fig 1](#pone.0169739.g001){ref-type="fig"}) were obtained from GenBank ([www.ncbi.nlm.nih.gov/](http://www.ncbi.nlm.nih.gov/)). The Clustal Multiple Alignment Algorithm was used on the V1-V2 and V3-V4 regions common to the *env* of all the above FIV subtypes to identify polymorphic regions that would enable us to differentiate between subtypes. The primers to amplify the polymorphic regions were synthesized by GenScript (GenScript, Nanjing, China). Standard PCRs were performed with the primers we designed against a 374-bp segment in the V1-V2 region (forward: `GAAGAAGGAAATGCAGGTAAGTTTAGAA`; reverse: `GGTGCCCAACAATCCCAAAA`) and a 680-bp segment of V3-V5 (forward: `ATACCAAAATGTGGATGGTGGAA`; reverse: `TAATCCTGCTACTGGGTTATACCAATT`). The primers for the V1-V2 region (first segment of the *env*) amplify subtypes A to E while those for the V3-V5 region (second segment of *env*) detect all subtypes (A to F and U-NZenv). Positive controls consisted of FIV subtypes A, B and C identified in a previous study \[[@pone.0169739.ref024]\]. The standard PCRs were performed in a Roche LightCycler II PCR platform. Each reaction was performed with a 20μl final volume containing 10μl of extracted nucleotides, 1×PCR buffer, 1μM forward primer, 1μM reverse primer, 2 unit Taq DNA polymerase and 200μM dNTP. Thermal cycling consisted of 18 high-stringency step-down cycles followed by 30 relaxed-stringency cycles. The cycling parameters for PCR were 6 × 1 sec at 95°C, 12 sec at 72°C, 30 sec at 72°C; 9 × 1 sec at 95°C, 12 sec at 70°C, 30 sec at 72°C; 3 × 1 sec at 95°C, 12 sec at 68°C, 30 sec at 72°C; 30 × 1 sec at 95°C, 8 sec at 56°C, 30 sec at 67°C, 30 sec at 72°C. Products were verified by gel electrophoresis and sequenced with forward and reverse primers using the Sanger method (BGI, Shanghai, China).

![Phylogeny of *gag* and *env* genes of FIV.\
*Gag* sequences (176-bp) of FIV strains identified in this study and representatives of the five subtypes with sequences in GenBank. In addition, a 374-bp region encompassing V1 to V2 is shown on the left of the bottom panel, and a 502-bp region encompassing V3 to V5 on the right panel. The *env* sequences of the FIV strains identified in this study (in red) are compared with the sequences of representatives of the FIV subtypes with sequences in GenBank; five for V1 to V2 and seven for V3 to V5. Branch lengths are measured in nucleotide substitutions and numbers show branching percentages in bootstrap replicates. Scale bar represents the percent sequence diversity.](pone.0169739.g001){#pone.0169739.g001}

The *gag* and *env* sequences we obtained were aligned with similar sequences in GenBank with the Clustalx 1.83 alignment software. Phylogenetic trees were constructed by the neighbor-joining method using the Kimura 2-parameter model with MEGA 6.0. Bootstrap values calculated using 500 replicates.

Results {#sec003}
=======

We analyzed blood samples from 615 cats from Beijing (n = 138), Guangzhou (75), Nanjing (146), Shanghai (143) and Yangzhou (113). Background data was available for 514 cats of which 383 were owned and kept mainly indoors and 131 were strays; 278 were male and 236 were female. Estimated age data was available for 458 cats which were placed into one of the following arbitrary age groups: 68 kittens (\< 6 m), 225 young adults (6 m to 4 yrs), 101 adults (4 to 10yrs) and 64 older cats (\>10yrs).

The FRET-PCR followed by confirmatory sequencing showed that 1.3% (8/615) of the cats were positive for FIV. All the FIV-positive cats were male cats from Guangzhou (n = 1), Shanghai (3) and Nanjing (4) ([Table 1](#pone.0169739.t001){ref-type="table"}). Seven of these 8 FIV-positive cats were sick with clinical signs such as stomatitis, salivation and anorexia. The melting point and the *gag* sequence analyses of the FRET-PCR showed all the positive sequences belonged to FIV subtype A. They had 97%-99% (2-5/164 nucleotide mismatches) similarity with the FIV subtype A TN7 strain (GQ422127) from Canada, and 97%-98% (2-4/164 mismatches) similarity with a FIV subtype A CaONA07 strain (AY225009) from Canada.

10.1371/journal.pone.0169739.t001

###### FIV-positive cats identified in this study.

![](pone.0169739.t001){#pone.0169739.t001g}

  Cat    City        Age (year)   Gender          Source                      Health status
  ------ ----------- ------------ --------------- --------------------------- ------------------------------
  C18    Guangzhou   1.0          Neutered male   Domestic cat                Renal failure
  C180   Nanjing     3.0          Intact male     Feral cat                   Stomatitis
  C181   Nanjing     3.0          Intact male     Feral cat before adoption   Depression
  C171   Nanjing     1.5          Intact male     Feral cat before adoption   Stomatitis
  C172   Nanjing     3.0          Intact male     Domestic cat                Stomatitis
  C174   Shanghai    0.25         Intact male     Domestic cat                Fever, 41.3°C
  C176   Shanghai    3.0          Neutered male   Domestic cat                Feline calicivirus infection
  C78    Shanghai    10.0         Intact male     Domestic cat                Apparently healthy

The sequences of the V1-V2 *env* region (GenBank accession number: KX710096- KX710097 and KX904827-KX904832) in the positive cats were all similar (90%-97% identity) with six being most closely related to the UK2 strain. This is a FIV subtype A from Scotland (X69494) which has 91% similarity with C18, C172, C176 and C180 (32--34 mismatches) and 93% similarity with C78 and C174 (26 and 28 mismatches, respectively) \[[@pone.0169739.ref025]\]. In the remaining two positive cats, one (C171) had a strain most closely related to the Sendai1 strain, a FIV subtype A from Japan (D37814) (91% similarity, 32/374), and the other (C181) a strain with 91% similarity to UK2 strain and Sendai1 strain (38/374). ([Table 2](#pone.0169739.t002){ref-type="table"}) \[[@pone.0169739.ref026]\].

10.1371/journal.pone.0169739.t002

###### Percent similarities (upper-right diagonal half) and actual numbers of mismatches (lower-left diagonal half) in the *env* V1-V2 sequences (374bp) of two FIV positive cats from China and representatives of the four FIV subtypes with sequences on GenBank.

![](pone.0169739.t002){#pone.0169739.t002g}

  ------------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------- ---------- ----- ----- --------- ------ ----- ----- ---------- ---------
                                              C18      C78      C171     C172     C174     C176     C180     C181     UK2      Sendai1   UK8   Dixon   Petaluma   PPR   FDS   Sendai2   USIL   C     C36   Shizuoka   Fukuoka
  C18[^a^](#t002fn001){ref-type="table-fn"}            93       90       93       93       90       93       92       **91**   90        88    90      89         85    76    76        73     65    65    70         70
  C78                                         27                92       94       98       94       94       94       **93**   92        89    92      92         85    76    75        72     66    65    71         70
  C171                                        36       28                93       93       90       94       92       90       **91**    87    89      88         84    75    73        71     66    66    70         70
  C172                                        28       24       26                94       91       97       94       **91**   91        88    91      89         84    77    75        72     66    66    72         71
  C174                                        28       7        25       22                94       95       94       **93**   92        89    92      92         85    76    75        72     66    65    71         70
  C176                                        38       22       40       34       22                91       91       **91**   90        88    90      89         84    77    76        73     66    65    71         69
  C180                                        28       22       24       12       19       34                95       **91**   91        88    91      90         84    76    74        71     66    66    72         71
  C181                                        31       28       32       24       26       38       21                **91**   **91**    87    90      89         84    75    74        72     67    66    71         70
  A-UK2                                       **33**   **28**   37       **32**   **26**   **34**   **32**   **38**            90        88    91      90         83    75    74        71     66    64    70         69
  A-Sendai1                                   38       29       **32**   34       28       38       34       **38**   37                 88    91      90         84    76    74        72     66    66    69         67
  A-UK8                                       43       41       37       43       40       46       46       53       44       44              88      87         90    76    75        72     66    66    69         68
  A-Dixon                                     38       31       43       35       31       37       34       41       34       36        44            91         84    76    74        72     65    64    70         67
  A-Petaluma                                  42       31       46       40       31       43       38       46       37       37        49    34                 85    77    76        74     66    66    72         70
  A-PPR                                       56       55       62       61       56       61       59       63       65       60        40    60      57               76    75        72     66    65    69         67
  A/B-FDS                                     91       91       95       89       90       87       93       98       96       92        90    92      89         91          95        94     68    68    70         71
  B-Sendai2                                   94       97       102      96       96       93       101      104      100      99        96    99      94         96    19              97     67    67    70         70
  B-USIL2489                                  103      106      113      107      107      104      111      112      109      108       107   106     102        105   24    12               66    65    68         69
  C-C                                         133      131      131      129      133      133      130      130      133      129       131   136     128        131   126   129       134          95    63         64
  C-C36                                       133      134      132      130      136      136      130      133      137      132       131   140     130        134   124   130       137    20          64         65
  D-Shizuoka                                  114      111      114      107      111      113      107      115      114      119       105   115     105        120   111   114       119    143   143              92
  D-Fukuoka                                   116      114      116      110      116      117      110      118      119      125       120   125     115        125   110   113       118    140   139   32         
  ------------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------- ---------- ----- ----- --------- ------ ----- ----- ---------- ---------

^a^ The GenBank Accession numbers of the China strains are C18(KX710096); C78 (KX710097), C171 (KX904827), C172 (KX904828), C174 (KX904829), C176 (KX904830), C180 (KX904831) and C181 (KX904832), while those of previously reported FIV are: subtype A, UK2 (X69494), Sendai1 (D37813), UK8 (X69496), Dixon (L00607), Petaluma (M25381), PPR (M36968); subtype A/B, FDSydneyC36 (KP330229); subtype B, Sendai2 (D37814), USIL2489 (U11820); subtype C, C (AF474246), C36 (AY600517); subtype D, Shizuoka (D37811), Fukuoka (D37815).

The sequences of the *env* V3-V5 segment amplicons of the eight positive cats (GenBank accession number: KX646706-KX646707 and KX904833-KX904838) differed by 3%-7% (27--53 mismatches) ([Table 3](#pone.0169739.t003){ref-type="table"}). Five were most closely related to the UK2 strain, a FIV subtype A from Scotland (X69496), with 94--95% similarity (38--43 mismatches) to C171, C172, C174, C176 and C180 ([Table 3](#pone.0169739.t003){ref-type="table"}) \[[@pone.0169739.ref019]\]. The other three positivities were most closely related to FIV subtype A/B strain FDSydneyC36 from Australia (KP330229) which had 94% (636/677) identity with C18, 96% (652/683) identity with C78 and 95% (638/680) identity with C181, respectively ([Table 3](#pone.0169739.t003){ref-type="table"}, [Fig 1](#pone.0169739.g001){ref-type="fig"}) \[[@pone.0169739.ref026]\].

10.1371/journal.pone.0169739.t003

###### Percent similarities (upper-right diagonal half) and actual numbers of mismatches (lower-left diagonal half) in the *env* V3-V5 sequences (C18:677bp and C78:683bp) of two FIV positive cats from China and representatives of each of the seven FIV subtypes with sequences on GenBank.
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  ------------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------- ----- ---------- -------- --------- ------ ----- ----- ---------- --------- ----- ------
                                              C18      C78      C171     C172     C174     C176     C180     C181     UK8      Sendai1   UK2   Dixon   PPR   Petaluma   FDS      Sendai2   USIL   C     C36   Shizuoka   Fukuoka   LP3   LP20
  C18[^a^](#t003fn001){ref-type="table-fn"}            94       93       94       93       94       94       95       93       93        93    91      90    90         **94**   81        80     79    79    79         80        82    82
  C78                                         45                95       95       97       96       94       94       95       94        93    93      90    92         **96**   80        80     80    79    80         81        81    81
  C171                                        53       40                95       94       95       94       94       **94**   94        93    92      91    90         94       81        80     79    80    79         80        80    80
  C172                                        44       38       38                96       95       96       96       **95**   94        93    94      91    92         95       81        79     80    80    79         80        81    81
  C174                                        53       27       40       34                95       94       95       **94**   94        92    92      90    91         95       80        78     78    78    78         80        80    80
  C176                                        51       34       36       36       34                94       94       **94**   94        93    92      91    91         94       81        80     80    80    80         81        81    81
  C180                                        51       47       42       32       42       42                95       **94**   93        93    93      90    91         94       80        79     80    80    80         80        80    80
  C181                                        48       47       45       34       38       42       33                94       93        93    92      90    92         **95**   80        79     79    79    80         81        81    81
  UK8                                         56       42       **40**   **38**   **38**   **42**   **43**   49                95        94    93      90    92         95       80        79     79    80    79         81        81    81
  A-Sendai1                                   50       43       49       46       49       51       59       55       44                 93    93      90    92         96       80        79     80    80    79         80        80    80
  A-UK2                                       56       49       49       51       53       51       51       49       44       55              92      90    90         94       80        79     80    80    79         81        81    81
  A-Dixon                                     66       49       55       49       56       55       49       55       47       54        59            89    92         94       81        80     80    79    81         81        81    80
  A-PPR                                       68       70       70       69       79       72       80       78       77       72        72    80            88         91       82        82     82    82    80         81        81    81
  A-Petaluma                                  73       55       70       65       67       62       67       63       58       65        69    56      91               92       81        79     78    79    80         81        81    80
  A/B-FDS                                     **41**   **31**   45       40       42       45       46       **42**   40       32        45    50      70    60                  81        80     80    80    80         81        81    81
  B-Sendai2                                   143      147      140      142      148      140      141      142      144      159       138   139     137   141        141                95     81    80    82         86        85    85
  B-USIL2489                                  145      147      144      148      152      141      144      144      150      152       154   146     136   149        145      41               80    80    83         87        84    85
  C-C                                         156      154      150      148      157      148      144      152      150      147       153   156     142   159        150      138       137          99    80         80        80    80
  C-C36                                       153      153      146      146      154      144      144      148      145      146       150   154     139   156        147      139       135    13          80         80        80    81
  D-Shizuoka                                  160      147      150      154      159      146      152      152      152      153       150   150     148   142        146      131       126    151   148              92        82    82
  D-Fukuoka                                   144      138      139      140      141      133      136      133      135      145       143   141     139   140        139      102       87     139   137   70                   85    84
  E-LP3                                       138      141      139      140      139      135      142      133      135      144       146   141     142   139        138      106       109    143   136   137        108             95
  E-LP20                                      136      141      139      138      141      133      140      135      139      147       144   143     140   143        139      104       104    139   133   139        115       35    
  ------------------------------------------- -------- -------- -------- -------- -------- -------- -------- -------- -------- --------- ----- ------- ----- ---------- -------- --------- ------ ----- ----- ---------- --------- ----- ------

^a^ The GenBank Accession numbers of the China strains are C18 (KX646706), C78 (KX646707), C171 (KX904833), C172 (KX904834), C174 (KX904835), C176 (KX904836), C180 (KX904837) and C181 (KX904838), while those of previously reported FIV are: subtype A, UK8 (X69496), Sendai1 (D37813), UK2 (X69494), Dixon (L00607), PPR (M36968), Petaluma (M25381); subtype A/B, FDSydneyC36 (KP330229); subtype B, Sendai2 (D37814), USIL2489 (U11820); subtype C, C (AF474246), C36 (AY600517); subtype D, Shizuoka (D37811), Fukuoka (D37815); subtype E, LP3 (D84496), LP20 (D84498).

The phylogenetic trees we generated ([Fig 1](#pone.0169739.g001){ref-type="fig"}) that were based on the nucleotide sequences of our mainland China FIV strains and representative strains of FIV from GenBank clearly demonstrated that our Chinese strains were members of subtype A. In addition, the V3-V5 amino acid sequences of the envelop protein for FIV cats in this study were aligned with those of representative strains of FIV from GenBank ([Fig 2](#pone.0169739.g002){ref-type="fig"}).

![Alignment of amino acid of FIV on envelop protein V3-V5 regions.\
V3-V5 region amino acid sequences of FIV strains identified in this study (red font) were aligned with those of representatives FIV subtypes in GenBank (black for subtype A, blue for subtype A/B; green for subtype B; orange for subtype C, pink for subtype D, and brown for subtype E). Identical nucleotides at given positions are represented by dots (·), gaps are represented by dashes (-).](pone.0169739.g002){#pone.0169739.g002}

Discussion {#sec004}
==========

The results of our study confirm the presence of the FIV in mainland China and add to the known distribution range of the virus in the country. We found a low prevalence but the cats we studied were predominantly indoor pets that had little contact with other cats. Elsewhere, such cats also have a low prevalence of infection, for example 0.7% in the USA \[[@pone.0169739.ref024]\]. Why we found no infected cats in the shelter population from Yangzhou is unclear, as feral cats often have a high prevalence of FIV infection, for example 18% in the US \[[@pone.0169739.ref024]\].

Previous studies have shown cats infected with FIV do not have decreased longevity \[[@pone.0169739.ref027]\] and that it is only after relatively prolonged infection that immunosuppression occurs and clinical signs become apparent \[[@pone.0169739.ref028]\]. It was unexpected, then, that seven of the cats we found positive for FIV clinically ill although still relatively young (3 years of age or younger). Unfortunately, there was little or no laboratory data available on these cats and we were not able to establish what, if any, role the FIV infections might have played in the clinical signs that were reported.

Previous studies have shown that PCRs for FIV provirus detection can have a wide range of sensitivities (41--93%) \[[@pone.0169739.ref029]\]. This relatively poor sensitivity might be as a result of the very low levels of provirus that can be present in infected cats, particularly in apparently healthy animals, but can also be due to variability in the proviral genome of the FIV; there can be up to 26% polymorphism between serotypes in the *env* and *gag* \[[@pone.0169739.ref030], [@pone.0169739.ref031]\]. Further, recombination with sometimes complex patterns resulting from co-infections or super-infections is also not uncommon in the FIVs \[[@pone.0169739.ref009], [@pone.0169739.ref032]\]. Because of the wide range of subtypes of FIVs and their high evolutionary rate, it is difficult to develop a PCR that is generic enough to amplify all subtypes and yet maintain high sensitivity \[[@pone.0169739.ref033]\]. The FRET-PCR we used against the *gag* has been shown to be sensitive, detecting single copies of the target, and capable of differentiating FIV subtypes A, B, C, D and E \[[@pone.0169739.ref024]\]. Similarly, the primers we developed against the V1-V2 region of the first segment of the *env* gene amplified subtypes A to E and enabled their differentiation with sequencing. We could not establish if our primers amplified subtype F and subtype U-NZenv as there are no sequence data for this region on GenBank for these two serotypes. There is sequence data, however, for the V3-V5 region of all the FIV subtypes and the primers we developed for this second segment of the *env* were capable of detecting all subtypes, that is A to F and also U-NZenv. The PCRs we performed in our study thus enabled us to detect low copy numbers of FIV and also to detect all the recognized subtypes.

In our study, all the FIV positive isolates we detected belonged to subtype A which occurs widely around the world with most isolates being from Australia, New Zealand, North America, South Africa and Europe \[[@pone.0169739.ref010], [@pone.0169739.ref034]\]. Isolates from countries closer to mainland China have included subtypes A, B, C and D from Japan \[[@pone.0169739.ref014]\], subtype C from Korea and Vietnam \[[@pone.0169739.ref013], [@pone.0169739.ref035]\], and subtype D from Thailand \[[@pone.0169739.ref036]\]. Our description of subtype A in mainland China is thus the first description of this subtype in the country and, to the best of our knowledge, on the mainland of Asia.

Of note is our finding that the sequences of the second segment of the *env* in three of our mainland China FIV strains (C18, C78 and C181) were very similar to the FDSydneyC36 (41, 31 and 42 mismatches, respectively) ([Table 3](#pone.0169739.t003){ref-type="table"}, [Fig 2](#pone.0169739.g002){ref-type="fig"}). The sequences of the first segment of the *env*, however, were relatively distant (91, 91 and 98 mismatches, respectively), being more closely aligned with representatives of the FIV subtype B ([Table 2](#pone.0169739.t002){ref-type="table"}, [Fig 2](#pone.0169739.g002){ref-type="fig"}). This difference is explained by the fact that the FDSydneyC36 strain, from a cat immunized with a commercial FIV vaccine \[[@pone.0169739.ref026]\], is a recombinant strain of FIV, subtype A/B. The second segment of the *env* is assigned to subtype A while the first segment is assigned to subtype B.

Our findings of FIV subtype A and the serological evidence of infections presented by Cong et al. \[[@pone.0169739.ref023]\] should alert Chinese veterinarians to the possibility of infections in their feline patients. Although clinical signs resulting from FIV infection are highly variable and unpredictable, cats infected with subtype A have been found to remain asymptomatic for longer and have lower viral loads than cats infected with subtype C \[[@pone.0169739.ref034], [@pone.0169739.ref037], [@pone.0169739.ref038]\]. The subtype A FIV strains are often neurotrophic and can produce neurological signs, most commonly behavioral changes but also seizures, paresis, multifocal motor abnormalities, impaired learning and disrupted sleep patterns \[[@pone.0169739.ref005]\]. Currently there is only one registered FIV vaccine which is composed of two FIV subtypes, A and D. The vaccine is reported to confer protection against subtypes A, B and D and might then be useful in mainland China where \[[@pone.0169739.ref032], [@pone.0169739.ref039]\], to the best of our knowledge, vaccination is seldom if ever performed. A recent study, however, has shown the vaccine does not confer solid protection and breakthroughs were found with FIV subtypes A, F, A/F and D/F \[[@pone.0169739.ref040]\]. Further studies on the usefulness of vaccination under conditions of natural challenge are required, particularly in Asian countries where subtype C is prevalent.

In conclusion, our study has shown that FIV subtype A occurs in mainland China and continental Asia. Larger studies are indicated to further determine the subtypes present in the region which will facilitate the development of accurate diagnostic tools and control programs.
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